Topical β-blocker therapy and central nervous system side effects: a preliminary study comparing betaxolol and timololLYNCH, M. G; WHITSON, J. T; BROWN, R. H et al.Archives of ophthalmology (1960). 1988, Vol 106, Num 7, pp 908-911, issn 0003-9950Article

Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitisCALDWELL, D. R; VERIN, P; HARTWICH-YOUNG, R et al.American journal of ophthalmology. 1992, Vol 113, Num 6, pp 632-637, issn 0002-9394Article

Betaxolol in patients with glaucoma and asthmaVAN BUSKIRK, E. M; WEINREB, R. N; BERRY, D. P et al.American journal of ophthalmology. 1986, Vol 101, Num 5, pp 531-534, issn 0002-9394Article

Long-term betaxolol therapy in glaucoma patients with pulmonary diseaseWEINREB, R. N; VAN BUSKIRK, E. M; CHERNIACK, R et al.American journal of ophthalmology. 1988, Vol 106, Num 2, pp 162-167, issn 0002-9394Article

Topical β-blocker therapy and central nervous system side effects: a preliminary study comparing betaxolol and timololLYNCH, M. G; WHITSON, J. T; BROWN, R. H et al.Archives of ophthalmology (1960). 1988, Vol 106, Num 7, pp 908-911, issn 0003-9950, 4 p.Article